1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Omuro, A. M. P.; Correa, D.; Moskowitz, C.; Matasar, M. J.; DeAngelis, L. M.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Anemia and functional disability in older adults with cancer
    Meeting Abstract

    Owusu, C.; Tew, W. P.; Hardt, M.; Mohile, S. G.; Klepin, H. D.; Gross, C. P.; Gajra, A.; Lichtman, S. M.; Ramani, R.; Katheria, V.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Clinical characteristics of ALK plus NSCLC patients (pts) treated with crizotinib beyond disease progression (PD): Potential implications for management
    Meeting Abstract

    Otterson, G. A.; Riely, G. J.; Shaw, A. T.; Crino, L.; Kim, D. W.; Martins, R.; Salgia, R.; Zhou, C.; Solomon, B. J.; Wilner, K. D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Outcomes of patients older than 60 years with acute lymphoblastic leukemia: Survey from the Surveillance, Epidemiology, and End Results (SEER) program
    Meeting Abstract

    Park, J. H.; Devlin, S.; Tallman, M. S.; Douer, D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Does unblinding of treatment assignment impact participant perceptions in clinical trials?
    Meeting Abstract

    Partridge, A. H.; Sepucha, K.; O'Neill, A. M.; Miller, K.; Motley, C.; Swaby, R. F.; Schneider, B. P.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Multiplex testing for driver mutations in squamous cell carcinomas of the lung
    Meeting Abstract

    Paik, P. K.; Hasanovic, A.; Wang, L.; Rekhtman, N.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Tenosynovial giant cell tumor (TGCT)/pigmented villonodular synovitis (PVNS): Outcome of 313 patients before the era of kinase inhibitors
    Meeting Abstract

    Palmerini, E.; Pengo, S.; Maki, R. G.; Staals, E. L.; Cioffi, A.; Alberghini, M.; Picci, P.; Ruggieri, P.; Mapelli, S.; Parafioriti, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Carboplatin dosing in the treatment of epithelial ovarian cancer (EOC): A Gynecologic Oncology Group (GOG) study
    Meeting Abstract

    O'Cearbhaill, R. E.; Miller, A.; Muggia, F.; Smith, J. A.; Bookman, M. A.; Sabbatini, P.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The SELECT study: A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Neal, J. W.; Pennell, N. A.; Govindan, R.; Lanuti, M.; Rosovsky, R. P. G.; Heist, R. S.; Shaw, A. T.; Temel, J. S.; Muzikansky, A.; Janne, P. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC)
    Meeting Abstract

    Nichols, C.; Mitchell, S. A.; Lang, K.; Federico, V.; Castro, K. M.; Rogak, L. J.; Lalla, D.; Clauser, S. B.; Reeve, B. B.; Denicoff, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save